Explore the full record of transactions filed by 차현주, Directeur Exécutif. Officer active across 2 companies, notably 온코닉테라퓨틱스. In total, 17,943 filings have been logged. Activity tracked since 4 March 2026. The latest transaction was disclosed on 4 March 2026 (Purchase). Regulator: DART (FSS). The full history is openly available.
Cha Hyun-joo is an Executive Director at Onconic Therapeutics. He is responsible for leading the company's strategic initiatives and overseeing operations. His expertise in the biotechnology field allows him to guide the company in developing innovative therapeutic solutions. He plays a crucial role in achieving the company's objectives.